BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23212367)

  • 1. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart.
    Xie J; Cha SK; An SW; Kuro-O M; Birnbaumer L; Huang CL
    Nat Commun; 2012; 3():1238. PubMed ID: 23212367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho May Ameliorate Proteinuria by Targeting TRPC6 Channels in Podocytes.
    Kim JH; Xie J; Hwang KH; Wu YL; Oliver N; Eom M; Park KS; Barrezueta N; Kong ID; Fracasso RP; Huang CL; Cha SK
    J Am Soc Nephrol; 2017 Jan; 28(1):140-151. PubMed ID: 27151926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-intensity interval training increases myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury.
    Ramez M; Ramezani F; Nasirinezhad F; Rajabi H
    Exp Physiol; 2020 Apr; 105(4):652-665. PubMed ID: 32052504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.
    Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA
    Circ Res; 2014 Feb; 114(5):823-32. PubMed ID: 24449818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.
    Han X; Ross J; Kolumam G; Pi M; Sonoda J; King G; Quarles LD
    J Am Soc Nephrol; 2018 Jan; 29(1):69-80. PubMed ID: 28993502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
    Xie J; Wu YL; Huang CL
    Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The greater effect of high-intensity interval training versus moderate-intensity continuous training on cardioprotection against ischemia-reperfusion injury through Klotho levels and attenuate of myocardial TRPC6 expression.
    Ramez M; Rajabi H; Ramezani F; Naderi N; Darbandi-Azar A; Nasirinezhad F
    BMC Cardiovasc Disord; 2019 May; 19(1):118. PubMed ID: 31096903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
    Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
    Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Munc13 mediates klotho-inhibitable diacylglycerol-stimulated exocytotic insertion of pre-docked TRPC6 vesicles.
    Xie J; An SW; Jin X; Gui Y; Huang CL
    PLoS One; 2020; 15(3):e0229799. PubMed ID: 32134975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
    Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
    J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].
    Nishida M; Watanabe K; Nakaya M; Kurose H
    Yakugaku Zasshi; 2010 Mar; 130(3):295-302. PubMed ID: 20190513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
    Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
    J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TRPC3 and TRPC6 channels in the myocardial response to stretch: Linking physiology and pathophysiology.
    Yamaguchi Y; Iribe G; Nishida M; Naruse K
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):264-272. PubMed ID: 28645743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.
    Wright JD; An SW; Xie J; Yoon J; Nischan N; Kohler JJ; Oliver N; Lim C; Huang CL
    FASEB J; 2017 Aug; 31(8):3574-3586. PubMed ID: 28442546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling.
    Camacho Londoño JE; Tian Q; Hammer K; Schröder L; Camacho Londoño J; Reil JC; He T; Oberhofer M; Mannebach S; Mathar I; Philipp SE; Tabellion W; Schweda F; Dietrich A; Kaestner L; Laufs U; Birnbaumer L; Flockerzi V; Freichel M; Lipp P
    Eur Heart J; 2015 Sep; 36(33):2257-66. PubMed ID: 26069213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
    EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ca2+ channels as novel therapeutic targets in heart failure].
    Kuwahara K
    Nihon Yakurigaku Zasshi; 2012 Dec; 140(6):255-8. PubMed ID: 23229630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.